Northwest Biotherapeutics Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Public

  • Employees
  • 25

Employees

  • Stock Symbol
  • NWBO

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $0.46
  • (As of Friday Closing)

Northwest Biotherapeutics General Information

Description

Northwest Biotherapeutics Inc is a biotechnology company involved in the development of cancer vaccines. The target is a broad range of solid-tumor cancers. The company has a proprietary manufacturing technology, which it uses to produce a personalized vaccine. The product portfolio includes product candidates such as DCVax-L, for patients with brain cancer; DCVax-Direct, direct injection into all types of inoperable solid tumor cancers, and DCVax for late-stage ovarian cancer. DCVax-Prostate, for late-stage prostate cancer, has received clearance from the U.S. Food and Drug Administration.

Contact Information

Website
www.nwbio.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Corporate Office
  • 4800 Montgomery Lane
  • Suite 800
  • Bethesda, MD 20814
  • United States
+1 (240) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Northwest Biotherapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.46 $0.47 $0.40 - $1.09 $556M 1.21B 1.66M -$0.07

Northwest Biotherapeutics Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 679,747 867,856 860,860 671,624
Revenue 1,336 1,932 1,683 1,005
EBITDA (62,691) (55,625) (97,464) 184,723
Net Income (70,259) (62,599) (105,032) 179,126
Total Assets 28,567 27,865 31,323 40,160
Total Debt 49,077 45,560 26,253 37,938
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Northwest Biotherapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Northwest Biotherapeutics‘s full profile, request access.

Request a free trial

Northwest Biotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Northwest Biotherapeutics Inc is a biotechnology company involved in the development of cancer vaccines. The target is a
Drug Discovery
Bethesda, MD
25 As of 2023
00000
000000000 - 00000

0000 0

erit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur s
0000 000000000
Cambridge, MA
00 As of 0000
00000
00000000 00000

000000

im veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commo
0000 000000000
Bothell, WA
0000 As of 0000
00.000
000.00 0000-00-00
000000&0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Northwest Biotherapeutics Competitors (59)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aura Biosciences Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
Seagen Formerly VC-backed Bothell, WA 0000 00.000 000000&0 00.000
Oncorus Formerly VC-backed Andover, MA 00 00000 000000000000 00000
Advanced Proteome Therapeutics Corporation Boston, MA 0 000 000000000 000
Achaogen Formerly VC-backed South San Francisco, CA 00 00000 0000000000.
You’re viewing 5 of 59 competitors. Get the full list »

Northwest Biotherapeutics Executive Team (8)

Name Title Board Seat Contact Info
Marnix Bosch Ph.D Chief Technology Officer
Alton Boynton Ph.D Chief Scientific Officer & Founder
Les Goldman Senior Vice President & General Counsel, Legal
Linda Powers JD Chief Executive Officer & Chief Financial Officer, Finance
You’re viewing 4 of 8 executive team members. Get the full list »

Northwest Biotherapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Northwest Biotherapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Northwest Biotherapeutics‘s full profile, request access.

Request a free trial

Northwest Biotherapeutics Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Flaskworks 28-Aug-2020 0000000000 00.00 Other Devices and Supplies 00000 000
MithraGen 01-Jan-2008 Merger/Acquisition Biotechnology
To view Northwest Biotherapeutics’s complete acquisitions history, request access »

Northwest Biotherapeutics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Northwest Biotherapeutics’s complete esg history, request access »

Northwest Biotherapeutics FAQs

  • When was Northwest Biotherapeutics founded?

    Northwest Biotherapeutics was founded in 1996.

  • Who is the founder of Northwest Biotherapeutics?

    Alton Boynton Ph.D is the founder of Northwest Biotherapeutics.

  • Who is the CEO of Northwest Biotherapeutics?

    Linda Powers JD is the CEO of Northwest Biotherapeutics.

  • Where is Northwest Biotherapeutics headquartered?

    Northwest Biotherapeutics is headquartered in Bethesda, MD.

  • What is the size of Northwest Biotherapeutics?

    Northwest Biotherapeutics has 25 total employees.

  • What industry is Northwest Biotherapeutics in?

    Northwest Biotherapeutics’s primary industry is Drug Discovery.

  • Is Northwest Biotherapeutics a private or public company?

    Northwest Biotherapeutics is a Public company.

  • What is Northwest Biotherapeutics’s stock symbol?

    The ticker symbol for Northwest Biotherapeutics is NWBO.

  • What is the current stock price of Northwest Biotherapeutics?

    As of 21-Jun-2024 the stock price of Northwest Biotherapeutics is $0.46.

  • What is the current market cap of Northwest Biotherapeutics?

    The current market capitalization of Northwest Biotherapeutics is $556M.

  • What is Northwest Biotherapeutics’s current revenue?

    The trailing twelve month revenue for Northwest Biotherapeutics is $1.34M.

  • Who are Northwest Biotherapeutics’s competitors?

    Aura Biosciences, Seagen, Oncorus, Advanced Proteome Therapeutics, and Achaogen are some of the 59 competitors of Northwest Biotherapeutics.

  • What is Northwest Biotherapeutics’s annual earnings per share (EPS)?

    Northwest Biotherapeutics’s EPS for 12 months was -$0.07.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »